Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion type Assertion NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_head.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion description "[These data suggest that the combination of TRA-8 treatment with specific overexpression of Bax using AdVEGFBax may be an effective approach for the treatment of human malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_provenance.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion evidence source_evidence_literature NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_provenance.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion SIO_000772 14973547 NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_provenance.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion wasDerivedFrom befree-2016 NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_provenance.
- NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_assertion wasGeneratedBy ECO_0000203 NP432352.RAB8P8r6glwR33MqlFM1EhM7a1eG-53_xz08lA6npTBhY130_provenance.